(Q51687256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

title

The role of antileukotrienes in the treatment of asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

author name string

G. Riccioni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

N. D'Orazio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

S. Sensi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

R. Spoltore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

M. De Benedictis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

M. T. Guagnano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

C. Di Ilio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

C. Schiavone

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

E. Ballone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

R. Della Vecchia

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopathology and Pharmacology

18 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

page(s)

171-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations

18 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Evolution of asthma through childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Adult patients may outgrow their asthma: a 25-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Formation and actions of leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Characterization of the human cysteinyl leukotriene CysLT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Changing patterns of asthma hospitalization among children: 1979 to 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Review of prescribed treatment for children with asthma in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Inhaled budesonide for treatment of recurrent wheezing in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Leukotriene modifiers in pediatric asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Persistent increase in plasma and urinary leukotrienes after acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Leukotriene antagonists and symptom control in chronic persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Efficacy of antileukotriene agents in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Discovery of leukotrienes and development of antileukotriene agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Safety of antileukotriene agents in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

What is "more effective asthma control"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Leukotriene receptor antagonists in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Nasal Mucosal Involvement in Systemic Lupus Erythematosus: Histopathologic and Immunopathologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500303

10.1177/039463200201500303

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12575917%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference